# Entrada Therapeutics, Inc.: Form 8-K, filed Nov 2, 2021

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: 8-K
- Filed: 2021-11-02
- Accepted by EDGAR: Nov 2, 2021, 16:01 ET
- Period: 2021-10-28
- Accession: 0001104659-21-132980
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/tm2131671d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/tm2131671d1_8k.htm

Filed Nov 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-132980. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.